Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001992324-26-000010

EVP, CFO & CBO sold 124,042 shares at an average $90.52 ($11,228,720)

  • EVP, CFO & CBO acquired 124,042 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Savitz Ryan · EVP, CFO & CBO

Table I: Non-derivative

19 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-09 Exercise or conversion : show line 1 in the form 10b5-1 +29,276 $17.88 $523,455 29,276 D
2026-11-09 Exercise or conversion : show line 2 in the form 10b5-1 +20,608 $21.77 $448,636 49,884 D
2026-11-09 Exercise or conversion : show line 3 in the form 10b5-1 +40,430 $22.07 $892,290 90,314 D
2026-11-09 Exercise or conversion : show line 4 in the form 10b5-1 +10,399 $8.44 $87,768 100,713 D
2026-11-09 Sale : show line 5 in the form 10b5-1 −300 $85.16 $25,548 100,413 D
2026-11-09 Sale : show line 6 in the form 10b5-1 −700 $86.70 $60,690 99,713 D
2026-11-09 Sale : show line 7 in the form 10b5-1 −1,736 $88.84 $154,226 97,977 D
2026-11-09 Sale : show line 8 in the form 10b5-1 −37,517 $90.12 $3,381,032 60,460 D
Open-market sales · 124,042 sh · avg $90.52 · $11,228,720

Table II: Derivative

10 lines
Date Transaction Shares Owned after D/I
2026-11-09 Exercise or conversion : show line 20 in the form 10b5-1 Stock Option (Right to Buy) −29,276 42,500 D
2026-11-09 Exercise or conversion : show line 21 in the form 10b5-1 Stock Option (Right to Buy) −20,608 48,143 D
2026-11-09 Exercise or conversion : show line 22 in the form 10b5-1 Stock Option (Right to Buy) −40,430 109,570 D
2026-11-09 Exercise or conversion : show line 23 in the form 10b5-1 Stock Option (Right to Buy) −10,399 0 D
2026-11-10 Exercise or conversion : show line 24 in the form 10b5-1 Stock Option (Right to Buy) −1,301 46,842 D
2026-11-10 Exercise or conversion : show line 25 in the form 10b5-1 Stock Option (Right to Buy) −1,260 108,310 D
2026-11-11 Exercise or conversion : show line 26 in the form 10b5-1 Stock Option (Right to Buy) −1,744 45,098 D
2026-11-11 Exercise or conversion : show line 27 in the form 10b5-1 Stock Option (Right to Buy) −1,300 107,010 D
2026-11-12 Exercise or conversion : show line 28 in the form 10b5-1 Stock Option (Right to Buy) −1,339 43,759 D
2026-11-12 Exercise or conversion : show line 29 in the form 10b5-1 Stock Option (Right to Buy) −16,385 90,625 D
Loading xslF345X06/ownership.xml…